https://edu.efclif.com Sat, 15 Aug 2026 16:59:43 +0000 hourly 1 https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video-crafting-robust-inclusion-and-exclusion-criteria/comment-page-1/#comment-283 Sat, 15 Aug 2026 16:59:43 +0000 https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video/#comment-283 Exlusion remove factors that counfound outcomes; priotitize participant safety

]]> https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video-crafting-robust-inclusion-and-exclusion-criteria/comment-page-1/#comment-282 Sat, 15 Aug 2026 16:58:58 +0000 https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video/#comment-282 IC anchor the develepment of thte drug

]]> https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video-crafting-robust-inclusion-and-exclusion-criteria/comment-page-1/#comment-281 Sat, 15 Aug 2026 16:58:31 +0000 https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video/#comment-281 inclusion criteria —ensure that target population matches the evaluate primary objecitve and MoA of the drug. Feasibility matters

]]> https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video-crafting-robust-inclusion-and-exclusion-criteria/comment-page-1/#comment-280 Sat, 15 Aug 2026 16:56:39 +0000 https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video/#comment-280 eleigbility strategic – narrow criteria increase validity internal reduccing noysy. External-by reflecting is real world patient

]]> https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video-crafting-robust-inclusion-and-exclusion-criteria/comment-page-1/#comment-279 Sat, 15 Aug 2026 16:54:33 +0000 https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video/#comment-279 External validity: is whether our finding are apllyed the real woprld-population -generalization. Are representative the population? how representative:

]]> https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video-crafting-robust-inclusion-and-exclusion-criteria/comment-page-1/#comment-278 Sat, 15 Aug 2026 16:53:32 +0000 https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video/#comment-278 Validity (internal and external) Internal is whether observed effects are truly due to the intervention? Dehliver has this internal validity- and is defines how well the trial includes the control of bias and confounding factors….( randomozation, yes, blinding to reduce measurement, yes, and performances bias, high follow rates? , protocol adherence, and appropiate SA main tool to protect internal validity.

]]> https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video-defining-your-target-population/comment-page-1/#comment-277 Sat, 15 Aug 2026 16:42:18 +0000 https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video/#comment-277 see last slide-priciples of population selection

]]> https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video-defining-your-target-population/comment-page-1/#comment-276 Sat, 15 Aug 2026 16:40:36 +0000 https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video/#comment-276 exlusion -inclusion criteria, should be limited and according to the underlying disease trayectory

]]> https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video-defining-your-target-population/comment-page-1/#comment-275 Sat, 15 Aug 2026 16:39:31 +0000 https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video/#comment-275 drug MoA aligns with the physiopatology of the disease to act to the select population

]]> https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video-defining-your-target-population/comment-page-1/#comment-274 Sat, 15 Aug 2026 16:37:40 +0000 https://edu.efclif.com/courses/implementation-of-prospective-clinical-research/lessons/video/#comment-274 from a study trial design perspective enrolling patients with such such divergent prognosis introduces substantial variability that can diluce treat effect, complicate endpoints interpretation and ultimately reduce ability to the detect a true terapeutic signal:

]]>